Promoting wellbeing through active ageing

The effect of individualized counselling on promoting active ageing and wellbeing

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16172390

Enrollment

200

Registered

2017-08-30

Start date

2017-09-20

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active ageing and wellbeing Not Applicable

Interventions

The overall goal of the 12-month counseling intervention is to promote active aging, that is, any participation in valued life activities. The intervention development is based on the COM-B model and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 30/05/2018: 1. Living independently in the community 2. Aged 75 or 80 years 3. University of Alabama at Birmingham Life-Apace mobility Assessment (LSA) score between 52.3 - 90.0 4. No evident cognitive decline 5. Participants will be recruited from a cohort study Previous inclusion criteria: 1. Living independently in the community 2. Age 75, 80 or 85 3. University of Alabama at Birmingham Life-Apace mobility Assessment (LSA) score between 52.3 - 90.0 4. No evident cognitive decline 5. Participants will be recruited from a cohort study

Exclusion criteria

Exclusion criteria: 1. Mini-Mental State Examination score (MMSE) of 24 or lower 2. Unwillingness to participate

Design outcomes

Primary

Measure	Time frame
Active ageing, measured using the University of Jyväskylä Active Aging scale (UJACAS) pre-trial, at 6 months and at 12 months (post-trial)	—

Secondary

Measure	Time frame
Current secondary outcome measures as of 30/05/2018: 1. Wellbeing, assessed with the Ryff scale pre- and post-trial 2. Depressive symptoms, assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) pre- and post-trial 3. Quality of life, assessed using the Older People’s Quality of Life questionnaire (OPQOL-brief) pre- and post-trial 4. Autonomy in outdoor mobility, assessed using a subscale of the Impact of Participation and Autonomy scale (IPA) pre- and post-trial 5. Mobility, assessed with the University of Alabama at Birmingham Life-space mobility assessment (LSA) pre- and post-trial 6. Physical activity, assessed objectively with trial axial accelerometers and using self-reports (the Yale Physical Activity Survey for Older Adults [YAPS]) pre- and post-trial 7. Personal goals studied with an open-ended question modified from the Personal Project Analysis 8. Autonomy in outdoor mobility assessed with the ‘autonomy outdoors’ subscale of the Impact on Participation and Autonomy questionnaire Previous secondary outcome measures: 1. Wellbeing, assessed with the Ryff scale pre- and post-trial 2. Depressive symptoms, assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) pre- and post-trial 3. Quality of life, assessed using the Older People’s Quality of Life questionnaire (OPQOL-brief) pre- and post-trial 4. Autonomy in outdoor mobility, assessed using a subscale of the Impact of Participation and Autonomy scale (IPA) pre- and post-trial 5. Mobility, assessed with the University of Alabama at Birmingham Life-space mobility assessment (LSA) pre- and post-trial 6. Physical activity, assessed objectively with trial axial accelerometers and using self-reports (the Yale Physical Activity Survey f	—

Measure

Time frame

Current secondary outcome measures as of 30/05/2018: 1. Wellbeing, assessed with the Ryff scale pre- and post-trial 2. Depressive symptoms, assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) pre- and post-trial 3. Quality of life, assessed using the Older People’s Quality of Life questionnaire (OPQOL-brief) pre- and post-trial 4. Autonomy in outdoor mobility, assessed using a subscale of the Impact of Participation and Autonomy scale (IPA) pre- and post-trial 5. Mobility, assessed with the University of Alabama at Birmingham Life-space mobility assessment (LSA) pre- and post-trial 6. Physical activity, assessed objectively with trial axial accelerometers and using self-reports (the Yale Physical Activity Survey for Older Adults [YAPS]) pre- and post-trial 7. Personal goals studied with an open-ended question modified from the Personal Project Analysis 8. Autonomy in outdoor mobility assessed with the ‘autonomy outdoors’ subscale of the Impact on Participation and Autonomy questionnaire Previous secondary outcome measures: 1. Wellbeing, assessed with the Ryff scale pre- and post-trial 2. Depressive symptoms, assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) pre- and post-trial 3. Quality of life, assessed using the Older People’s Quality of Life questionnaire (OPQOL-brief) pre- and post-trial 4. Autonomy in outdoor mobility, assessed using a subscale of the Impact of Participation and Autonomy scale (IPA) pre- and post-trial 5. Mobility, assessed with the University of Alabama at Birmingham Life-space mobility assessment (LSA) pre- and post-trial 6. Physical activity, assessed objectively with trial axial accelerometers and using self-reports (the Yale Physical Activity Survey f

—

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026